For the Inventor, By the Inventor

Enter assignee name

Wilmington, MA, United States of America

Chemgenes Corporation

USPTO Granted Patents = 21

EPO Patents = 3

Trademarks = 1

Forward Citations = 255

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Suresh C Srivastava (20 out of 59 patents)

Naveen P Srivastava (10 out of 10 patents)

Sant K Srivastav (5 out of 8 patents)

4. Satya P Bajpai (4 out of 4 patents)

5. Divya Pandey (3 out of 3 patents)

6. Andrei Laikhter (3 out of 15 patents)

7. Syed K Raza (3 out of 3 patents)

8. Stanley J Szymanski, Jr (2 out of 4 patents)

9. Praveen K Shukla (1 out of 2 patents)

10. Amy Arrow (1 out of 14 patents)

11. Satya P Bajpal (1 out of 1 patent)

12. Satya K Bajpai (1 out of 1 patent)

13. Kwok-Hung Sit (1 out of 1 patent)

14. Alok Kumar Srivastava (1 out of 54 patents)

15. Santhosh Kumar Thatikonda (1 out of 3 patents)

21 patents: Sort by Forward Citations

1. 11634762 - RT-qPCR molecular detection and diagnosis (2023-04-25),

2. 10167308 - Highly efficient synthesis of long RNA using reverse direction approach (2019-01-01),

3. 9884885 - Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis (2018-02-06),

4. 9718855 - Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA and as diagnostics tools (2017-08-01),

5. 9605261 - RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end (2017-03-28),

6. 9441002 - Dithiolane based thiol modifier for labeling and stronger immobilization of bio-molecules on solid surfaces (2016-09-13),

7. 8981076 - Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis (2015-03-17),

8. 8933214 - RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end (2015-01-13),

9. 8785619 - Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA potential diagnostics tools (2014-07-22),

10. 8778996 - Method of treating a human being for a class of neurological defects and seizure disorders (2014-07-15),

11. 8618279 - Synthesis of 2',3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides (2013-12-31),

12. 8541569 - Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA (2013-09-24),

13. 8530634 - Method of oligonucleotide labeling using cycloaddition reaction (2013-09-10),

14. 8309707 - RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end (2012-11-13),

15. 7956169 - Synthesis of novel azo-dyes and their use in oligonucleotide synthesis (2011-06-07),

Company Overview

Chemgenes Corporation is a biotechnology firm based in Wilmington, MA, specializing in the development and manufacture of custom oligonucleotides and related products. The company focuses on providing high-quality solutions for research and diagnostic applications in molecular biology, genomics, and synthetic biology. With a commitment to innovation, Chemgenes supports a diverse range of clients, including academic institutions, pharmaceutical companies, and biotechnology firms, enhancing their capabilities in genetic research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#20 in Wilmington, MA

#945 in Massachusetts

#15,695 in US

#29,961 in the World

Wilmington, MA, United States of America

Chemgenes Corporation

Forward Citations = 255

18 inventors:

Suresh C Srivastava (20 out of 59 patents)

Naveen P Srivastava (10 out of 10 patents)

Sant K Srivastav (5 out of 8 patents)

4. Satya P Bajpai (4 out of 4 patents)

5. Divya Pandey (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chemgenes Corporation. Retrieved from https://idiyas.com/company/chemgenes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…